S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday.
The Dow traded up 0.19% to 38,313.56 while the NASDAQ rose 0.13% to 15,948.81. The S&P 500 also rose, gaining, 0.10% to 5,105.25.
Check This Out: Jim Cramer Likes Palantir, Recommends Pioneer Natural Resources: ‘I Want You To Ka-Ching, Ka-Ching’
Leading and Lagging Sectors
Consumer discretionary shares rose by 1.9% on Monday.
In trading on Monday, communication services shares fell by 1.7%.
Top Headline
ON Semiconductor Corp (NASDAQ:ON) reported better-than-expected first-quarter results.
ON Semiconductor reported a fiscal first-quarter 2024 revenue decline of 5% year-on-year to $1.86 billion, beating the consensus of $1.85 billion. The adjusted EPS of $1.08 beat the consensus of $1.04.
ON Semiconductor expects second-quarter adjusted revenue of $1.68 billion – $1.78 billion, below the consensus of $1.92 billion. The company sees adjusted EPS of $0.86 – $0.98 versus the consensus of $1.10.
Equities Trading UP
- Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) shares shot up 73% to $25.29 after the company announced it will be acquired by ONO Pharmaceutical for $25.60 per share in cash.
- Shares of Collective Audience, Inc. (NASDAQ:CAUD) got a boost, surging 84% to $0.7356 after the company announced a strategic partnership with Insticator.
- Koninklijke Philips N.V. (NYSE:PHG) shares were also up, gaining 28% to $27.02 after the company announced $1.1 billion settlement for Respironics personal injury and medical monitoring litigation. The company also reported better than expected first-quarter earnings and reaffirmed guidance.
Equities Trading DOWN
- Clever Leaves Holdings Inc. (NASDAQ:CLVR) shares dropped 61% to $1.60 after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister its Securities to terminate and suspend its reporting obligations.
- Shares of Addex Therapeutics Ltd (NASDAQ:ADXN) were down 50% to $8.12 after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.
- Annovis Bio, Inc. (NYSE:ANVS) was down, falling 58% to $7.49 after the company announced data from its Phase II/III Alzheimer study of buntanetap in mild to moderate Alzheimer’s. Efficacy in the CGIC endpoint was not reached due to the limited number of patients and short trial duration.
Also Check This Out: This Analyst With 86% Accuracy Rate Sees Around 13% Upside In Chipotle Mexican Grill – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts
Commodities
In commodity news, oil traded down 0.8% to $83.17 while gold traded up 0.4% at $2,355.80.
Silver traded up 0.6% to $27.410 on Monday, while copper rose 2.1% to $4.67.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.07%, London's FTSE 100 rose 0.09% while Spain's IBEX 35 Index fell 0.48% The German DAX fell 0.24% French CAC 40 fell 0.29% while Italy's FTSE MIB Index rose 0.14%.
The services confidence indicator in the Eurozone fell by 0.4 points to 6.0 in April, while industry confidence indicator declined to -10.5 in April versus a revised level of -8.9 in the prior month. The consumer confidence indicator in the Eurozone increased by 0.2 points to -14.7 in April.
The seasonally adjusted industry confidence indicator in Spain increased by 0.8 points from the prior month to a reading of -3.9 in April. Spain’s consumer price inflation rate rose to 3.3% year-over-year in April.
Asia Pacific Markets
Asian markets closed higher on Monday, with Hong Kong's Hang Seng Index jumping 0.54%, China's Shanghai Composite climbing 0.79% and India's S&P BSE Sensex gaining 1.28%.
Profits earned by Chinese industrial firms climbed 4.3% year-over-year to CNY 1,505.5305 billion during the first three months of the year, compared to a 10.2% gain in the earlier period.
Economics
The Dallas Fed Manufacturing index fell slightly to -14.5 in April from March’s reading of -14.4.
Now Read This: Top 3 Real Estate Stocks That Are Set To Fly In April